Literature DB >> 16863506

Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.

Yo Fujii1, Masayoshi Yada, Masaaki Nishiyama, Takumi Kamura, Hidehisa Takahashi, Ryosuke Tsunematsu, Etsuo Susaki, Tadashi Nakagawa, Akinobu Matsumoto, Keiichi I Nakayama.   

Abstract

Fbxw7 (also known as Sel-10, hCdc4 or hAgo) is the F-box protein component of a Skp1-Cul1-F-box protein (SCF) ubiquitin ligase. Fbxw7 contributes to the ubiquitin-mediated degradation of cyclin E, c-Myc, Aurora-A, Notch and c-Jun, all of which appear to function as cell-cycle promoters and oncogenic proteins. Loss of Fbxw7 results in elevated expression of its substrates, which may lead to oncogenesis. However, it remains largely unclear which accumulating substrate is most related to cancer development in Fbxw7-mutant cancer cells. In the present study, we examined the abundance of cyclin E, c-Myc and Aurora-A in seven cancer cell lines, which harbor wild-type (three lines) or mutant (four lines) Fbxw7. Although these three substrates accumulated in the Fbxw7-mutant cells, the extent of increase in the expression of these proteins varied in each line. Forced expression of Fbxw7 reduced the levels of cyclin E, c-Myc and Aurora-A in the Fbxw7-mutant cells. In contrast, a decrease in the expression of cyclin E, c-Myc or Aurora-A by RNA interference significantly suppressed the rate of proliferation and anchorage-independent growth of the Fbxw7-mutant cells. These findings thus suggest that the loss of Fbxw7 results in accumulation of cyclin E, c-Myc and Aurora-A, all of which appear to be required for growth promotion of cancer cells. Fbxw7 seems to regulate the levels of multiple targets to suppress cancer development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863506     DOI: 10.1111/j.1349-7006.2006.00239.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  37 in total

1.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

2.  The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.

Authors:  Madhurima Biswas; Diane Phan; Momoko Watanabe; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

3.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

4.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

5.  p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.

Authors:  Chun-Chi Wu; Tsung-Ying Yang; Chang-Tze Ricky Yu; Liem Phan; Cristina Ivan; Anil K Sood; Shih-Lan Hsu; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

6.  C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.

Authors:  Snehalata A Pawar; Tapasree Roy Sarkar; Kuppusamy Balamurugan; Shikha Sharan; Jun Wang; Youhong Zhang; Steven F Dowdy; A-Mei Huang; Esta Sterneck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

7.  Cullins and cancer.

Authors:  Jennifer Lee; Pengbo Zhou
Journal:  Genes Cancer       Date:  2010-07

8.  Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.

Authors:  Kuang-Yu Jen; Ihn Young Song; Karl Luke Banta; Di Wu; Jian-Hua Mao; Allan Balmain
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

9.  Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway.

Authors:  Stéphanie Duhamel; Charlotte Girondel; Jonas F Dorn; Pierre-Luc Tanguay; Laure Voisin; Ron Smits; Paul S Maddox; Sylvain Meloche
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

10.  Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7.

Authors:  Yaomin Chen; Haiyan Wei; Yu Liu; Shusen Zheng
Journal:  Oncol Lett       Date:  2018-01-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.